Videos / New pneumococcal 15-valent conjugate vaccine that includes coverage against serotype 3
In this Product Explainer, Public Health Physician and Infectious Diseases Epidemiologist Prof Paul Van Buynder explains the burden of pneumococcal disease in both children and adult population. He explains why PCV 15 has increased serotype coverage and why improved immunogenicity against serotype 3 is important both from a clinical and public health perspective (5 mins).
Maintaining Muscle Mass & Nutritional Status While Losing Weight on GLP-1RAs
Prostate Cancer Screening Recommendations – Case Discussion & Q&A
Dry Eye – Practical Management Tips for Better Outcome
Cardiovascular Outcomes & GLP1 – An Update
expert
Public Health Physician and Infectious Diseases Epidemiologist; Professor, School of Medicine, Griffith University, Queensland